The expression of PAK1 and BCAT1 along with mTORC1‐related proteins was increased in CLL patients compared with those in the control group, especially in refractory or relapsed CLL patients (Fig. 5E, Table S3). This evidence concerns the gene PAK1 and B-cell chronic lymphocytic leukemia.